The trend of Gaush Meditech's ROCE is not promising. Despite...
The trend of Gaush Meditech's ROCE is not promising. Despite the company's reinvestment in the business, the returns have been decreasing. This, coupled with the stock's significant decline over the past year, may not inspire investor confidence.
There Are Reasons To Feel Uneasy About Gaush Meditech's (HKG:2407) Returns On Capital
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment